Although CAT protein expression was not changed by the HC, BG supplementation significantly increased CAT expression in a dose-dependent manner, suggesting that BG enhances antioxidant enzyme activities in the liver of NAFLD mice (Figure 5b). Here, CAT is linked to metabolic dysfunction-associated steatotic liver disease.